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Abstract 
Review on PIP5K1A, with data on DNA, on the 










The cDNAs encoding the phosphatidylinositol 4-
phosphate 5-kinases (PIP5K) were isolated from the 
human brain using peptide sequences from the 
erythroid 68-kDa type I PIP5KI (Loijens 1996). A 
human fetal brain cDNA library was screened 
leading to isolation of full-length type IA, PIP5K1A 
cDNAs (Loijens 1996). PIP5K1A is located in the 
chromosomal region 1q21.3 (Xie 2000), the product 
of which is predominantly responsible for the 
synthesis of PtdIns-4,5-P2 (PIP2), a substrate used 
by PI3K to produce PtdIns-3,4,5-P3 (PIP3) (Shaw 
2006). PIP5K1A gene was localized to chromosome 
1q22-q24 by fluorescence in situ hybridization 
(FISH) (Xie 2000). 
Transcription 
The 549-amino acid protein has a conserved kinase 
homology domain similar to the rest of the PIP5K 
family members. Northern blot analysis showed a 
wide distribution of a PIP5K1A 4.2-kb transcript 
mostly expressed in skeletal muscle. In addition, 
high levels of PIP5K1A were also seen in heart, 
placenta, kidney, and pancreas while low levels of 
expression were observed in brain, liver, and lung 
(Loijens 1996). Deletion-mutant analysis was used 
to determine an approximately 380-amino acid 
minimal core sequence of mouse PIP5K1A that was 
sufficient for phosphatidylinositol 4-phosphate 
kinase activity. 
Protein 
Figure 1. Schematic representation of human PIP5K1A isoform with the conserved kinase core domain (adopted 
from Porciello 2016). 
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Description 
PIP5K1A is a 61-kDa protein migrating at about 68 
kDa in SDS-PAGE (Fruman 1998). The protein 
shows 83% and 35% amino acid identity with 
PIP5K1B and PIP4K2A (PIP5K2A), respectively,  
 
within the conserved kinase homology domain 
(Loijens 1996). Overall, the PIP5K1A and PIP5K1B 
proteins are 64% identical and Northern analysis 
shows the two to have a wide tissue distributions, but 
greatly differing expression levels. Recombinant, 
bacterially expressed PIP5KA was observed to have 
PIP5K activity and to be immunoreactive with 
erythroid PIP5KI antibodies (Loijens 1996). 
Furthermore, the authors isolated additional 
PIP5K1A cDNAs which they suggested represent 
splicing isoforms. Overexpression of mouse 
PIP5K1A in COS-7 cells stimulates an increase in 
short actin fibers and a decrease in actin stress fibers 
(Ishihara 1998). 
PIP5K1A mediate the phosphorylation of 
phosphatidylinositol 4-phosphate on the D5 position 
of the inositol ring, thus inducing the production of 
phosphatidylinositol 4,5-biphosphate (PIP2) (van 
den Bout 2009). In both humans and mice, all PIP5K 
isoforms show variation in their sequence by 
alternative splicing (Ishihara 1998). Three PIP5K1α, 
four β, and one γ splice variants were identified in 
humans and eight PIP5K1α, two β, and three γ splice 
variants are present in mice. (Ishihara 1998). 
All PIP5K isoforms α, β, and γ, and splice variants 
have a highly conserved kinase core domain that 
consists of 330-380 amino acids (Fig. 1), and a sub-
domain called the activation loop, that regulates their 
activity and subcellular localization (Tuosto 2015). 
The variables N- and C-termini of PIP5K isoforms 
are also involved in the regulation of lipid kinase 
activity and in targeting PIP5Ks to specific cellular 
compartments (Kwiatkowska 2010). The C-terminal 
residues (440-562) of PIP5K1A regulate its 
localization at nuclear speckles (Mellman 2008). 
The 83 C-terminal amino acids of PIP5K1β are 
essential for its polarization at the uropod (Lacalle 
2007), whereas the N-terminus controls PIP5K1β 
targeting to the plasma membrane and its 
dimerization with other PIP5K isoforms (Lacalle 
2015). (Ishihara 1998). 
The crystal structure of the catalytic domain of 
zebrafish PIP5K1A has been reported at 3.3Å 
resolution and the molecule forms a side-to-side 
dimer (Hu 2015). Mutagenesis study of PIP5K1A 
indicated two adjacent interfaces for the 
dimerization and interaction with the DIX domain of 
the Wnt signalling molecule dishevelled. Much as 
the interfaces were located distally to the 
catalytic/substrate-binding site, binding to these 
interfaces either through dimerization or the 
interaction with DIX stimulated PIP5K1 catalytic 
activity. DIX binding additionally enhanced PIP5K1 
substrate binding (Hu 2015). (Ishihara 1998). 
All the three PIP5K isoforms are expressed by 
primary T cells (Sun 2011) and they are triggered by 
phosphatidic acid (PA), which is generated by 
phospholipase D (PLD), through the hydrolysis of 
phosphatidylcholine (Jenkins 1994, Moritz 1992). 
PIP5K1α cooperates with PIP5Kβ and VAV1 in 
promoting actin polymerization and CD28 signaling 
functions in human T lymphocytes (Porciello 2016). 
PIP5K1A localises to the plasma membrane and the 
Golgi complex, and has also been observed at sites 
of membrane ruffling induced by the Rho GTPase 
RAC1 (van den Bout 2009). PIP5K1A in particular 
is recruited to the plasma membrane in response to 
several receptors to provide the substrate PIP2 for 
PLCγ leading to IP3 formation and Ca2+ 
mobilization (Saito 2003, Wang 2008 and Xie 2009). 
Both PIP5K1α and PIP5Kγ are known to interact and 
colocalize with phospholipase D 2 (PLD2) at the 
membrane to stimulate cell adhesion (Divecha 2000, 
Powner 2005). Some studies have also shown 
pronounced association of PIP5K1A with nuclear 
speckles (Chakrabarti 2013) where it may regulate 
pre-mRNA processing and mRNA export (Barlow 
2010). 
Function 
Treatment of primary cultured astrocytes with 
gangliosides significantly enhanced PIP5K1α 
mRNA and protein expression levels (Sang 2010). 
MicroRNA-based PIP5K1α knockdown strongly 
reduced ganglioside-induced transcription of 
proinflammatory cytokines. In addition, PIP5K1α 
knockdown suppressed phosphorylation and nuclear 
translocation of NF-kB (Sang 2010). 
PIPK-mediated mechanisms regulate microtubule 
dynamics in neuronal development (Noda 2012). 
Using immunoprecipitation with an antibody 
specific to KIF2A, PIPKα was identified as a 
candidate membrane protein that regulates the 
activity of KIF2A. Yeast two-hybrid and 
biochemical assays showed direct binding between 
KIF2A and PIPKα. Furthermore, the microtubule 
(MT)- depolymerizing activity of KIF2A was 




Some studies have shown that overexpression of 
PIP5K1α in non-malignant PNT1A cells induces the 
invasive capacity of these cells.  An increased 
expression of major factors that drive cancer cell 
proliferation and invasion such as VEGF, 
phosphorylated PTK2 (FAK), TWIST1, and MMP9, 
was observed in these cells due to PIP5K1α 
overexpression. PIP5K1α overexpression in these 
cells led to an increased AKT activity and an 
increased survival, as well as invasive malignant 
phenotype. The siRNA-mediated knockdown of 
PIP5K1α in these cells resulted into a reduced AKT 
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activity and an inhibition in tumor growth. PIP5K1α, 
PIP2 and PIP3 are important lipids for membrane 
structure and actin polymerization, thus increased 
levels of these lipids may lead to malignant 
transformation and progression of cancer cells into a 
more invasive phenotype (Semenas 2014). 
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